Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001415889-25-014167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-22 | 2025-05-20 | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.02 | -2,349 | 96.7K | -2% | -$63.5K |
| D | 2025-05-22 | 2025-05-20 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +2,349 | 99.0K | +2% | +$3,735 |
| D | 2025-05-22 | 2025-05-20 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -2,349 | 86.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-05-20 | S | D | 2,349 | $27.02 | 96,674 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.04. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2025-05-20 | M | A | 2,349 | $1.59 | 99,023 | D | — | — | |
| 3 | Derivative | Share Option | 2025-05-20 | M | D | 2,349 | $0.00 | 86,270 | D | $1.59 · — to 2025-12-15 | 2,349 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |